A Pilot Clinical Trial of Nitazoxanide in the Treatment of Chronic Hepatitis B
2019
Chronic infection by the hepatitis B virus (HBV) has remained a major public health problem. To achieve an HBV cure, we will likely need to combine antivirals with different viral targets as well as immunotherapy. Here, we report data from a pilot proof‐of‐concept clinical trial of nitazoxanide in treating chronic hepatitis B. Conclusion: Nitazoxanide offers novel mechanisms of antiviral activity, and it would be interesting to evaluate the potential of combining nitazoxanide with oral nucleos(t)ide analogues.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
6
References
13
Citations
NaN
KQI